The New Idea Award application process is now closed.
Introduction: The Leukemia & Lymphoma Society (LLS) is in its second year of The New Idea Award, a grant program designed to identify novel research strategies with high potential for high impact on the future of blood cancer treatment(s). Specifically, this program supports academic researchers with innovative ideas for approaches that are substantially different from standard therapies and prognostic/diagnostic modalities, as well as ideas that may fundamentally change our understanding of blood cancer(s). Successful awards will describe potentially paradigm-shifting ideas that take research in a substantially new direction, and thus preliminary data is not required.
Objectives: The goal of this program is to advance novel concepts that may eventually lead to significant improvements in the clinical outcomes, including quality of life, of patients with hematological malignancies. Grants will support initial exploration of untested but potentially transformative research ideas and treatment approaches. In order to receive such an award, applicants must succinctly describe the innovative idea/approach and a method for testing it within the one year grant period.
Upon completion of the one year period, awardees will be evaluated on the extent to which their concept has been substantiated by initial testing, and promising projects may be selected for extended funding. The long-term goal of The New Idea Award is to improve outcomes for more patients with hematological malignancies, recognizing that in some cases fundamental biological knowledge must first be achieved.
Grants are awarded in an amount of up to $100,000 for a one year grant period.